Invention Grant
- Patent Title: Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
-
Application No.: US15105076Application Date: 2014-12-17
-
Publication No.: US10556963B2Publication Date: 2020-02-11
- Inventor: Hergen Spits , Tim Beaumont , Marijn Aletta Gillissen , Adrianus Quirinus Bakker , Mette Deborah Hazenberg , Martijn Kedde
- Applicant: AIMM Therapeutics B.V.
- Applicant Address: NL Amsterdam Zuidoost
- Assignee: AIMM THERAPEUTICS B.V.
- Current Assignee: AIMM THERAPEUTICS B.V.
- Current Assignee Address: NL Amsterdam Zuidoost
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Gianna J. Arnold
- Priority: EP13197882 20131217
- International Application: PCT/NL2014/050873 WO 20141217
- International Announcement: WO2015/093949 WO 20150625
- Main IPC: C07K16/30
- IPC: C07K16/30 ; C07K16/06 ; A61K47/68 ; C07K16/40 ; C12P21/00 ; G01N33/574
Abstract:
The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.
Public/Granted literature
- US20160326261A1 MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS Public/Granted day:2016-11-10
Information query
